Peter Bartenstein - Concepedia

Author

Peter Bartenstein

Ludwig-Maximilians-Universität München ORCID

Also Known As

Andreas Delker, Bartenstein Peter, Bartenstein, P, Bartenstein, P., C. Trumm, F. Grünwald, Franziska Scheiwein, German Imaging Initiative for Tauopathies (GII4T), Kazunari Ishii, Kuangyu Shi

669

Publications

21K

Citations

H-Index

208

Concepts

All Affiliations

Ludwig-Maximilians-Universität München LMU Klinikum Munich Cluster for Systems Neurology German Center for Neurodegenerative Diseases Technical University of Munich

About

Peter Bartenstein is an author at Ludwig-Maximilians-Universität München specializing in medicine, health sciences, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	100	7.1K
2	Health Sciences	36	56	4.4K
3	Engineering	17	18	907
4	Public Health	2	2	57
5	Natural Sciences	1	1	10

Peter Bartenstein

309

Publications

19.2K

Citations

H-Index

Page 1

	Year	Citations
German Multicenter Study Investigating<sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil, Journal of Nuclear Medicine	2016	812
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study Henryk Barthel, Hermann‐Josef Gertz, S. Dresel, The Lancet Neurology Neurodegenerative DiseasesDiagnostic StudyAlzheimer's DiseaseCerebral Amyloid-β PetNeurochemical Biomarkers	2011	574
Nodal/Activin Signaling Drives Self-Renewal and Tumorigenicity of Pancreatic Cancer Stem Cells and Provides a Target for Combined Drug Therapy Enza Lonardo, Patrick Hermann, M Mueller, Cell stem cell Lineage PlasticityPancreatic CancerCombined Drug TherapyMedicineStem Cell Research	2011	412
Region-specific encoding of sensory and affective components of pain in the human brain: A positron emission tomography correlation analysis Thomas R. T�lle, Tanja Kaufmann, Thomas Siessmeier, Annals of Neurology	1999	394
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma Jens Ricke, Heinz‐Josef Klümpen, Holger Amthauer, Journal of Hepatology Surgical OncologyHepatologyRadiation TherapyMedicineLiver Cancer	2019	376
<sup>18</sup>F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease Axel Rominger, Tobias Saam, Sarah Wolpers, Journal of Nuclear Medicine	2009	352
Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer Andreas Delker, Wolfgang P. Fendler, Clemens Kratochwil, European Journal of Nuclear Medicine and Molecular Imaging Metastatic Prostate CancerUrologyMedicineNew RadiopharmaceuticalRadiopharmaceutical Therapy	2015	310
68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer Annika Herlemann, Vera Wenter, Alexander Kretschmer, European Urology Surgical OncologyUrologyOncologic ImagingMedical ImagingMedicine	2016	293
The <scp>FTD</scp> ‐like syndrome causing <scp>TREM</scp> 2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism Gernot Kleinberger, Matthias Brendel, Éva Mracskó, The EMBO Journal	2017	270
A Positron Emission Tomographic Study of Subthalamic Nucleus Stimulation in Parkinson Disease A Ceballos-Baumann, Henning Boecker, Peter Bartenstein, Archives of Neurology	1999	251

Page 1